In a University of Toronto simulation, AI scribes cut documentation from 36.3% of each primary care visit to 11.2%, though total visit length didn’t change significantly.
A study published in Advanced Science used three AI models to screen thousands of approved drugs, identifying nine that inhibit Streptococcus pneumoniae, a bacterium increasingly resistant to antibiotics.
New national research shows health systems and health plans still can't get provider data right — and the fallout lands squarely on physician practices
MGMA’s 100th-anniversary conference runs Sept. 27-30 in San Antonio, and these 10 sessions put physician contracts, compensation and legal exposure on the table.
Ballard Spahr says the Hikma v. Amarin decision makes it harder for brand-name drugmakers to sue over "skinny label" generics — a shift likely to speed generic competition and lower costs for patients